Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
Genome-wide variation in cell-free DNA end motif entropy predicts immunotherapy response in head and neck cancer.
Journal: The Journal of clinical investigation
Published: May 19, 2026
Genome-Wide Variations of End Motif in Cell-Free DNA Fragments Distinguish Immunotherapy Responders from Non-Responders in Head and Neck Cancer: A Multi-Institute Prospective Study.
Journal: medRxiv : the preprint server for health sciences
Published: April 10, 2026
Treatment Interruption and Outcomes in Head and Neck Cancer: A Secondary Analysis of 3 Randomized Clinical Trials.
Journal: JAMA otolaryngology-- head & neck surgery
Published: December 04, 2025
LoRA-fine-tuned Large Vision Models for Automated Assessment of Post-SBRT Lung Injury.
Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
Published: December 03, 2025
Long-Term Outcomes of Advanced Pneumatic Compression Device vs. Usual Care Therapy for Head and Neck Cancer-Related Lymphedema: A Multi-Site Randomized Clinical Trial.
Journal: International journal of radiation oncology, biology, physics
Published: November 28, 2025
The KRAS-Variant and Cetuximab in HPV-Positive Oropharyngeal Cancer: Results from the NRG/RTOG 1016 Trial.
Journal: Cancer research communications
Published: October 21, 2025
Genome-wide variation in cell-free DNA end-motif entropy predicts immunotherapy response in head and neck cancer.
Journal: The Journal of clinical investigation
Published: October 20, 2025
Short-Term Outcomes of Advanced Pneumatic Compression Device Versus Usual Care Therapy for Head and Neck Cancer-Related Lymphedema: A Multi-Site Randomized Clinical Trial.
Journal: Head & neck
Published: July 27, 2025
Head and Neck Mucosal Melanoma in the Era of Immunotherapy: A National Cancer Database Review.
Journal: Head & neck
Published: May 20, 2025
Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 22, 2025
Avasopasem manganese treatment for severe oral mucositis from chemoradiotherapy for locally advanced head and neck cancer: phase 3 randomized controlled trial (ROMAN).
Journal: EClinicalMedicine
Published: December 29, 2024
Long-Term Feeding Tube Use in Head and Neck Cancer Survivors-An Analysis of Patient- and Treatment-Related Factors.
Journal: International journal of radiation oncology, biology, physics
Published: November 12, 2024
Last Updated: 09/26/2026